Distribution of COVID‐19 mitigation measures by industry and work arrangement—US blood donors, May 2021–December 2021
American Journal of Industrial Medicine · 2024
DOI: 10.1002/ajim.23626 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2024. Verfasst von Dallas S Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinn…. Hauptthemen laut MEDLINE: COVID-19, Blood Donors, Workplace, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Objective
To describe coronavirus disease 2019 (COVID‐19) mitigation measures in workplaces of employed US blood donors by industry and work arrangement.
Methods
During May–December 2021, blood donors responded to a survey; we describe the distribution of reported workplace mitigation measures by industry and work arrangement, organized using the hierarchy of controls.
Results
Of 53,433 respondents representing 21 industries, ventilation upgrades were reported by 4%–38% of respondents (overall: 20%); telework access ranged from 14%–80% (53% overall). Requiring masks (overall: 84%; range: 40%–94%), physical distancing (77%; 51%–86%), paid leave for illness (70%; 38%–87%), and encouraging vaccination (61%; 33%–80%) were common. Independent workers reported fewer mitigation measures than those in traditional employment settings.
Conclusions
Mitigation measures varied by industry and work arrangement. Some mitigation measures may be challenging to implement or irrelevant in certain industries, supporting the idea that mitigation is not a one‐size‐fits‐all strategy. Policy Implications Tailored strategies to mitigate workplace risks of disease transmission are vital. Strategies should rely on effective methods for identifying workplace controls (e.g., through the hierarchy of controls) and account for industry‐specific characteristics and workplace environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
- Division of Coronaviruses and Other Respiratory Viruses, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Office of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
- American Red Cross, Scientific Affairs, Dedham, MA, Rockville, Maryland, USA.
ORCID-Profile: Dallas S Shi, Matthew R Groenewold
Förderung
- Intramural CDC HHS
Zitieren
APA
Shi, D. S., Rinsky, J. L., McDonald, E., Shah, M. M., Groenewold, M. R., de Perio, M. A., Feldstein, L. R., Saydah, S., Haynes, J. M., Spencer, B. R., Stramer, S. L., McCullough, M., Jones, J. M., & Chiu, S. K. (2024). Distribution of COVID‐19 mitigation measures by industry and work arrangement—US blood donors, May 2021–December 2021. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23626
Vancouver
Shi DS, Rinsky JL, McDonald E, Shah MM, Groenewold MR, de Perio MA, et al. Distribution of COVID‐19 mitigation measures by industry and work arrangement—US blood donors, May 2021–December 2021. American Journal of Industrial Medicine. 2024. doi:10.1002/ajim.23626
BibTeX
@article{Shi2024,
author = {Shi, Dallas S and Rinsky, Jessica L and McDonald, Emily and Shah, Melisa M and Groenewold, Matthew R and de Perio, Marie A and Feldstein, Leora R and Saydah, Sharon and Haynes, James M and Spencer, Bryan R and Stramer, Susan L and McCullough, Matthew and Jones, Jefferson M and Chiu, Sophia K},
title = {Distribution of COVID‐19 mitigation measures by industry and work arrangement—US blood donors, May 2021–December 2021},
journal = {American Journal of Industrial Medicine},
year = {2024},
doi = {10.1002/ajim.23626}
}
EUVIMED